デフォルト表紙
市場調査レポート
商品コード
1687622

末梢インターベンション市場規模、シェア、成長分析:介入タイプ別、デバイスタイプ別、適応症別、技術別、エンドユーザー別、地域別 - 産業予測 2025~2032年

Peripheral Interventions Market Size, Share, and Growth Analysis, By Intervention Type (Atherectomy, Stent Implantation), By Device Type (Catheters, Stents), By Indication, By Technology, By End User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 219 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
末梢インターベンション市場規模、シェア、成長分析:介入タイプ別、デバイスタイプ別、適応症別、技術別、エンドユーザー別、地域別 - 産業予測 2025~2032年
出版日: 2025年03月20日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

末梢インターベンション市場規模は2023年に102億米ドルと評価され、2024年の111億3,000万米ドルから2032年には223億4,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは9.1%で成長する見通しです。

高血圧、糖尿病、肥満、喫煙、高炭水化物食などの要因によって、心血管障害(CVD)の罹患率が上昇し、末梢インターベンションの需要を大きく牽引しています。この健康問題に対処するため、特に新興市場ではカテーテル検査室(カテラボ)の増加が世界的に顕著であり、それに伴いこの分野を専門とする医療従事者の数も増加しています。カテーテル検査室はCVDの診断と治療に不可欠な存在となりつつあり、特に開発途上国ではその存在感が拡大しています。心血管インターベンションにとどまらず、さまざまな手技をサポートするハイブリッドラボの登場は、業界の技術革新を浮き彫りにしています。例えば、インドのカテラボは、血管形成術の急増と時を同じくして、最近2倍以上に増加しており、その結果、世界の医療支出を押し上げ、末梢インターベンションサービスのさらなる成長が期待されています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析

末梢インターベンション市場規模:介入タイプ別& CAGR(2025-2032)

  • 市場概要
  • アテローム切除術
  • ステント留置術
  • 血管形成術
  • 血栓除去術
  • 塞栓術

末梢インターベンション市場規模:デバイスタイプ別& CAGR(2025-2032)

  • 市場概要
  • カテーテル
  • ステント
  • ガイドワイヤー
  • バルーン
  • 塞栓コイル

末梢インターベンション市場規模:適応症別& CAGR(2025-2032)

  • 市場概要
  • 冠動脈疾患
  • 脳卒中
  • 末梢動脈疾患
  • 腎動脈狭窄
  • 頸動脈狭窄症

末梢インターベンション市場規模:技術別& CAGR(2025-2032)

  • 市場概要
  • 薬剤溶出ステント
  • バルーン拡張型ステント
  • 自己拡張型ステント
  • 回転式アテレクトミー
  • 方向性アテレクトミー

末梢インターベンション市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • 病院
  • 外来手術センター
  • クリニック
  • 調査機関

末梢インターベンション市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Medtronic plc(Ireland)
  • Abbott Laboratories(USA)
  • Boston Scientific Corporation(USA)
  • Becton, Dickinson and Company(BD)(USA)
  • Philips(Netherlands)
  • Terumo Corporation(Japan)
  • Cook Medical(USA)
  • Cardinal Health, Inc.(USA)
  • B. Braun Melsungen AG(Germany)
  • Getinge AB(Sweden)
  • Merit Medical Systems, Inc.(USA)
  • BIOTRONIK SE & Co. KG(Germany)
  • Endologix, Inc.(USA)
  • ArtVentive Medical Group, Inc.(USA)
  • Inari Medical, Inc.(USA)
  • Bentley InnoMed GmbH(Germany)
  • Gore Medical(USA)
  • MicroPort Scientific Corporation(China)

結論と提言

目次
Product Code: SQMIG35D2214

Peripheral Interventions Market size was valued at USD 10.2 billion in 2023 and is poised to grow from USD 11.13 billion in 2024 to USD 22.34 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

The rising incidence of cardiovascular disorders (CVD) is significantly driving demand for peripheral interventions, fueled by factors like hypertension, diabetes, obesity, smoking, and high-carb diets. To address this health issue, there is a notable increase in catheterization laboratories (cath labs) globally, particularly in emerging markets, accompanied by a growing number of healthcare professionals specializing in this field. Cath labs are becoming essential for diagnosing and treating CVD, and their presence is expanding, especially in developing nations. The advent of hybrid labs, which support various procedures beyond cardiovascular interventions, highlights industry innovation. For instance, India's cath labs have more than doubled recently, coinciding with a surge in angioplasties, thereby boosting global healthcare spending and anticipating further growth in peripheral intervention services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Interventions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Interventions Market Segments Analysis

Global Peripheral Interventions Market is segmented by Intervention Type, Device Type, Indication, Technology, End User and region. Based on Intervention Type, the market is segmented into Atherectomy, Stent Implantation, Angioplasty, Thrombectomy and Embolization. Based on Device Type, the market is segmented into Catheters, Stents, Guide Wires, Balloons and Embolic Coils. Based on Indication, the market is segmented into Coronary Artery Disease, Stroke, Peripheral Arterial Disease, Renal Artery Stenosis and Carotid Artery Stenosis. Based on Technology, the market is segmented into Drug-Eluting Stents, Balloon-Expandable Stents, Self-Expanding Stents, Rotational Atherectomy and Directional Atherectomy. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Interventions Market

The increasing prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD), is a significant factor fueling the demand for peripheral intervention solutions. This surge in cases of cardiovascular conditions can largely be linked to risk factors such as hypertension, diabetes, obesity, and a lack of physical activity. As more individuals face these health challenges, there is an urgent need for effective peripheral therapies that address these issues. Consequently, healthcare providers and manufacturers are responding to this growing demand by developing and offering innovative treatment options tailored to manage and mitigate the effects of these cardiovascular disorders.

Restraints in the Peripheral Interventions Market

The Peripheral Interventions market faces significant limitations due to the high costs associated with these treatments, which can be a barrier for many individuals seeking care. In particular, those living in developed regions may find that expensive healthcare options hinder their access to necessary procedures. The financial strain imposed by these interventions can deter patients from pursuing them, ultimately affecting the overall growth and accessibility of the market. Consequently, the high cost of peripheral interventions remains a critical restraint that impacts patient choices and the market's expansion potential in various geographic areas.

Market Trends of the Peripheral Interventions Market

The Peripheral Interventions market is experiencing a significant trend towards the establishment of heterogeneous catheterization labs that integrate various invasive interventional treatments, including cardiac, vascular, neurological, and electrophysiological procedures. These hybrid facilities are gaining traction due to their flexibility, which allows healthcare providers to streamline operations and enhance patient outcomes by combining different specialties under one roof. This trend is driven by the demand for minimally invasive treatment options and the need for efficient patient management, propelling market growth. As technology advances and the focus shifts to personalized care, the hybridization of catheterization labs is set to revolutionize the landscape of peripheral interventions.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Peripheral Interventions Market Size by Intervention Type & CAGR (2025-2032)

  • Market Overview
  • Atherectomy
  • Stent Implantation
  • Angioplasty
  • Thrombectomy
  • Embolization

Global Peripheral Interventions Market Size by Device Type & CAGR (2025-2032)

  • Market Overview
  • Catheters
  • Stents
  • Guide Wires
  • Balloons
  • Embolic Coils

Global Peripheral Interventions Market Size by Indication & CAGR (2025-2032)

  • Market Overview
  • Coronary Artery Disease
  • Stroke
  • Peripheral Arterial Disease
  • Renal Artery Stenosis
  • Carotid Artery Stenosis

Global Peripheral Interventions Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Drug-Eluting Stents
  • Balloon-Expandable Stents
  • Self-Expanding Stents
  • Rotational Atherectomy
  • Directional Atherectomy

Global Peripheral Interventions Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Research Institutes

Global Peripheral Interventions Market Size & CAGR (2025-2032)

  • North America (Intervention Type, Device Type, Indication, Technology, End User)
    • US
    • Canada
  • Europe (Intervention Type, Device Type, Indication, Technology, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Intervention Type, Device Type, Indication, Technology, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Intervention Type, Device Type, Indication, Technology, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Intervention Type, Device Type, Indication, Technology, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOTRONIK SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Endologix, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ArtVentive Medical Group, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inari Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bentley InnoMed GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gore Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations